LDMIX | VEMRX | LDMIX / VEMRX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 16 years | 14 years | - |
Gain YTD | 8.524 | 11.274 | 76% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 10000 | 100000000 | 0% |
Min. Initial Investment IRA | 100000 | N/A | - |
Net Assets | 92.1M | 113B | 0% |
Annual Yield % from dividends | 2.15 | 3.48 | 62% |
Returns for 1 year | 13.83 | 14.73 | 94% |
Returns for 3 years | -9.47 | -3.96 | 239% |
Returns for 5 years | 5.08 | 17.74 | 29% |
Returns for 10 years | 26.35 | 25.50 | 103% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
SMOT | 36.37 | 0.57 | +1.59% |
VanEck Morningstar SMID Moat ETF | |||
PXF | 48.84 | 0.06 | +0.12% |
Invesco FTSE RAFI Dev Mkts ex-US ETF | |||
SBIO | 37.20 | 0.04 | +0.10% |
ALPS Medical Breakthroughs ETF | |||
FHYS | 23.18 | N/A | +0.02% |
Federated Hermes Short Duration HY ETF | |||
XYLE | 27.02 | -0.01 | -0.06% |
Global X S&P 500 ESG Covered Call ETF |